EMCURE PHARMACEUTICALS
|
The Current P/S Ratio of EMCURE PHARMACEUTICALS is 2.63.
Share Price | ₹1,033.3 | Apr 03,2025 |
Market Cap | ₹19,580.1 Cr | |
Sales-TTM | ₹7,447.4 Cr | TTM-Consolidated Results |
Price/Sales | 2.63x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of EMCURE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,580.1 Cr] as on Apr 03,2025
(/) Sales [ ₹7,447.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.63x ]
Thus, for EMCURE PHARMACEUTICALS , the investors are currently willing to pay '2.63 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of EMCURE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of EMCURE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of EMCURE PHARMACEUTICALS
PS Ratio Performance Analysis for EMCURE PHARMACEUTICALS
- EMCURE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- EMCURE PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, EMCURE PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 0x.
- EMCURE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does EMCURE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
EMCURE PHARMACEUTICALS | 7,447.4 | 2.63 | 19,580.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.23 | 424,706.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.85 | 152,946.0 |
CIPLA LTD | 26,981.2 | 4.48 | 120,751.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.73 | 109,988.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.08 | 96,066.7 |
MANKIND PHARMA LTD | 11,641.0 | 8.60 | 100,168.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.08 | 90,666.7 |
LUPIN LTD | 22,001.6 | 4.35 | 95,627.5 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.21 | 68,305.2 |
ABBOTT INDIA LTD | 6,243.2 | 10.19 | 63,621.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs EMCURE PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.21x |
Max industry PS | 16.85x |
Median industry PS | 4.48x |
Average industry PS | 6.77x |
You may also like the below Video Courses